Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2012 (Vol. 32, No. 6)

ClinLab Navigator

URL:www.clinlabnavigator.com
  • Hundreds of clinical test interpretations
  • Cluttered with advertisements, pdfs cost money

An aptly named website if ever I saw one, ClinLab Navigator is designed as a resource for medical professionals and researchers to demystify clinical laboratory tests. The site provides over 500 laboratory test interpretations, as well as an entire section devoted to transfusion guidelines. (The test interpretations are frequently updated, so the site reflects the most current state of the field.) The site design makes it unclear at first whether this information is freely accessible—indeed, the site looks as if it is selling something, and there are repeated mentions of purchasing a subscription. As it turns out, all of the information on the site is free…it’s only if you want a pdf version that it will cost you. It is unfortunate that the overall aesthetic of the website is poor. There are way too many advertisements, and it really does detract from the information being presented.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »